Ranbaxy swings back into profit in Q2 at Rs 478 cr

Consolidated revenue increases 16% to Rs 3,260 cr

Pharma company Ranbaxy Laboratories is back in black at Rs 478 crore for the quarter ended September 2014. The company reported net loss of Rs 454 crore in the same period a year ago.

The consolidated revenue increased 16% to Rs 3,260 crore from Rs 2,802 crore in September 2013.

On Tuesday, the company's stock on BSE was trading almost 5% higher at Rs 626 at 1345 hours.